Dr. MANSI SINGH

About

I am a pharmacology researcher with expertise in neuropharmacology, phytopharmacology, experimental pharmacology, and drug discovery. My research primarily focuses on identifying and evaluating plant-derived bioactive compounds with neuroprotective and anticonvulsant potential through in vitro, in vivo, and computational approaches.

I completed my Ph.D. in Pharmacology from GLA University, Mathura, India. My doctoral research investigated the neuroprotective and anticonvulsant effects of Galium verum L. and its bioactive flavonoid hispidulin against monosodium glutamate-induced neurotoxicity and epilepsy in experimental animal models.

My research interests include neurodegenerative disorders, epilepsy, oxidative stress, neuroinflammation, phytomedicine, molecular docking, drug screening, pharmacological evaluation of natural products, and translational neuroscience. I have authored numerous research articles, book chapters, and patents in the fields of pharmacology and pharmaceutical sciences.

I am committed to advancing evidence-based pharmaceutical research through interdisciplinary collaborations and innovative therapeutic approaches.

Employment

• Babasaheb Bhimrao Ambedkar University Assistant Professor/Resource person
  2025 - Present
• Rakshpal Bahadur Management Institute Assistant Professor
  2022 - 2025

Education

• GLA University Institute of Pharmaceutical Research PhD (Pharmacology)
  2021 - 2025
• Mahatma Jyotiba Phule Rohilkhand University M.pharm
  2017 - 2019
• Mahatma Jyotiba Phule Rohilkhand University B.Pharma
  2013 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Molecular Complexities of Dementia: PAISA Mutations and Targeting TAF2N as Therapeutic Avenues
  Current Gene Therapy 2026 DOI: 10.2174/0115665232389636251115111503
  +Save
• Strategic Directions for Addressing Human Metapneumovirus (HMPV) in India
  Infectious Disorders - Drug Targets 2026 DOI: 10.2174/0118715265384356250908115051
  +Save
• Formation and Structure of ecDNA in Cancer Cells
  Extrachromosomal DNA in Cancer 2026 DOI: 10.1201/9781003655299-2
  +Save
• TRX/TXNIP/miRs network in neuronal cells and TXNIP-targeted miRs modulate neuroinflammation, neuronal apoptosis, and mitochondrial dysfunction in Parkinson's disease: A review
  International Journal of Biological Macromolecules 2025 DOI: 10.1016/j.ijbiomac.2025.146878
  +Save
• Natural sesquiterpene lactones in prostate cancer therapy: mechanisms and sources
  Medical Oncology 2025 DOI: 10.1007/s12032-025-02740-2
  +Save
• A narrative review on the use of Green synthesized metallic nanoparticles for targeted cancer therapy
  Bioorganic Chemistry 2025 DOI: 10.1016/j.bioorg.2025.108305
  +Save
• Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
  Biochemical Pharmacology 2025 DOI: 10.1016/j.bcp.2025.116794
  +Save
• Investigating the Therapeutic Property of Galium verum L. (GV) for MSG induced Audiogenic Epilepsy (AEs) and Neuroprotection through In-Silico and In-Vitro Analysis
  Central Nervous System Agents in Medicinal Chemistry 2025 DOI: 10.2174/0118715249330123240822063420
  +Save
• Advances in Radiotherapy of Brain Tumors
  From Radiobiology to Radiation Oncology 2025 DOI: 10.1007/978-3-031-95724-6_12
  +Save
• Therapeutic Strategies for Chromium-Induced Neurotoxicity: Exploiting NPTX2 and Autophagy Pathways in CNS Cells
  2024 DOI: 10.3390/proceedings2024103022
  +Save